Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 44 checked references that resolve
resolves10.1586/erp.11.44Cancer-related fatigue: prevalence, assessment and treatment strategies
resolves10.1200/JCO.2011.34.6148Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study
resolves10.1016/j.bbi.2010.11.005Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: Brain substrates for fatigue?
resolves10.1210/jc.2013-4495Resistance Training Does Not Protect Against Increases in Plasma Cytokine Levels Among Germ Cell Cancer Patients During and After Chemotherapy
resolves10.1016/j.bbi.2010.09.010Fatigue and gene expression in human leukocytes: Increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue
resolves10.1016/j.eururo.2011.09.027Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature
resolves10.2174/092986709787002790Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
resolves10.1016/S0885-3924(96)00274-6Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
resolves10.1016/S0885-3924(02)00529-8Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales
resolves10.1001/archotol.134.5.528A Randomized, Placebo-Controlled Trial of Citalopram for the Prevention of Major Depression During Treatment for Head and Neck Cancer
resolves10.1089/neu.2008.0738Validation of Serum Markers for Blood-Brain Barrier Disruption in Traumatic Brain Injury
resolves10.1073/pnas.86.19.7611Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
resolves10.1074/jbc.M112.445510Induction of C-X-C Chemokine Receptor Type 7 (CXCR7) Switches Stromal Cell-derived Factor-1 (SDF-1) Signaling and Phagocytic Activity in Macrophages Linked to Atherosclerosis
resolves10.4049/jimmunol.170.11.5359Differential Regulation of Human Eosinophil IL-3, IL-5, and GM-CSF Receptor α-Chain Expression by Cytokines: IL-3, IL-5, and GM-CSF Down-Regulate IL-5 Receptor α Expression with Loss of IL-5 Responsiveness, but Up-Regulate IL-3 Receptor α Expression
resolves10.1002/glia.20544IFN‐γ‐induced IDO and WRS expression in microglia is differentially regulated by IL‐4
resolves10.1016/j.neulet.2006.11.007Interleukin-18 mediated inhibition of LTP in the rat dentate gyrus is attenuated in the presence of mGluR antagonists
resolves10.1002/art.24849Elevated insular glutamate in fibromyalgia is associated with experimental pain
resolves10.1248/bpb.35.481Effects of Memantine, an <i>N</i>-Methyl-<small>D</small>-aspartate Receptor Antagonist, on Fatigue and Neuronal Brain Damage in a Rat Model of Combined (Physical and Mental) Fatigue
resolves10.1016/j.neuroscience.2003.11.040Dissection of tumor-necrosis factor-α inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early—but not late—phase LTP
resolves10.1016/j.yfrne.2012.09.003Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise
resolves10.1038/npp.2013.115Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates
resolves10.1165/rcmb.2010-0004OCCross-Talk between Macrophage Migration Inhibitory Factor and Eotaxin in Allergic Eosinophil Activation Forms Leukotriene C4–Synthesizing Lipid Bodies
resolves10.1038/jid.2010.418Macrophage Migration Inhibitory Factor Is Essential for Eosinophil Recruitment in Allergen-Induced Skin Inflammation
The 11 references without a DOI — listed, not checked
no DOI — not checkedVariation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry
no DOI — not checkedInflammatory fatigue and sickness behaviour—lessons for the diagnosis and management of chronic fatigue syndrome
no DOI — not checkedLong-term efficacy and tolerability of abdominal once-yearly histrelin acetate subcutaneous implants in patients with advanced prostate cancer
no DOI — not checkedTreatment options for localized prostate cancer
no DOI — not checkedRadiation, inflammation and immune responses in cancer
no DOI — not checkedA novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitis
no DOI — not checkedInflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications
no DOI — not checkedThe blood brain barrier and the role of cytokines in neuropsychiatry
no DOI — not checkedIncreased eosinophil protein X levels in chronic fatigue syndrome
no DOI — not checkedMultiplex cytokine concentration measurement: how much do the medium and handling matter?
no DOI — not checkedPhysical exercise for functional capacity, blood immune function, fatigue and quality of life in high-risk prostate cancer patients during radiotherapy. A prospective, randomised clinical study
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.